ELAN CORPORATION, PLC LINCOLN HOUSE LINCOLN PLACE DUBLIN 2, IRELAND ELAN INTERNATIONAL SERVICES, LTD. 102 ST. JAMES COURT FLATTS, SMITHS PARISH BERMUDA FL 04Ligand Pharmaceuticals Inc • November 16th, 1998 • Pharmaceutical preparations • New York
EXHIBIT 10.1 (Date) (Name) (Address) Dear __________: The purpose of this letter agreement is to document the terms of the severance package to which you will be entitled should your employment with Ligand Pharmaceuticals Incorporated (the "Company")...Ligand Pharmaceuticals Inc • August 30th, 2006 • Pharmaceutical preparations
by and amongStockholders Agreement • December 5th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SETTLEMENT AGREEMENT, LICENSE AND MUTUAL GENERAL RELEASE This Settlement Agreement and Mutual General Release (the "Agreement"), having an effective date for all purposes of August 23, 1995, is made and entered into by and between La Jolla Cancer...Settlement Agreement • May 15th, 1997 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
EX-1.1 OTHERDOC 2 0002.txt JOINT FILING AGREEMENTJoint Filing Agreement • November 29th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G, dated November 29, 2002, (the "Schedule 13G"), with respect to the Common Stock, par value $0.001 per share, of Ligand Pharmaceuticals Incorporated is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
3 4 not misleading and (ii), in the case of the Prospectus, in light of the circumstances under which they were made, not misleading. When any related preliminary prospectus was first filed with the Commission (whether filed as part of the...Underwriting Agreement • October 22nd, 1996 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 2.3 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 15th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
ESCROW AGREEMENTEscrow Agreement • July 9th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
RECITALSStock Purchase Agreement • November 16th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 2.1 AMENDMENT NUMBER 2 TO PURCHASE AGREEMENT THIS AMENDMENT NUMBER 2 TO PURCHASE AGREEMENT, (this "AMENDMENT") entered into and effective this the 26th day of February, 2007 (the "EFFECTIVE DATE OF THIS AMENDMENT"), is made by and between...Purchase Agreement • February 28th, 2007 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
LIGAND LETTERHEAD} 1 March 2006 [Employee] Address City, State Zip Dear [Employee]: The purpose of this letter agreement between you and Ligand Pharmaceuticals, Inc. (the "Company") is to document the terms of a retention or stay bonus to which you...Ligand Pharmaceuticals Inc • March 7th, 2006 • Pharmaceutical preparations
EXHIBIT 4.5 PLEDGE AGREEMENT This PLEDGE AGREEMENT (this "PLEDGE AGREEMENT") is made and entered into as of November 26, 2002 by and between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (the "PLEDGOR"), and J.P. MORGAN TRUST COMPANY,...Pledge Agreement • January 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT Dated as of October 12, 2023 among LIGAND PHARMACEUTICALS INCORPORATED, as the Borrower, THE SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, CITIBANK, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and...Credit Agreement • October 18th, 2023 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of October 12, 2023, among Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein), and CITIBANK, N.A., as Administrative Agent, Swingline Lender and L/C Issuer.
EXHIBIT 10.13 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made as of the 30th day of September, 1999, by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (the "Company"), and Elan International Services, Ltd., a...Stock Purchase Agreement • November 15th, 1999 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 1.1 $135,000,000 Principal Amount Ligand Pharmaceuticals Incorporated 6% Convertible Subordinated Notes due 2007 PURCHASE AGREEMENT PURCHASE AGREEMENTPurchase Agreement • January 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 2.1 PURCHASE AGREEMENTPurchase Agreement • September 11th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.246 AMENDED AND RESTATED LICENSE AGREEMENT BETWEEN THE SALK INSTITUTE FOR BIOLOGICAL STUDIES AND LIGAND PHARMACEUTICALS INCORPORATEDLicense Agreement • August 14th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
AGREEMENTAgreement • July 9th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
Exhibit 99.3Stock Option Agreement • June 28th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 10.150 [USL CAPITAL LOGO] MASTER LEASE AGREEMENT [FORD FINANCIAL LOGO]Master Lease Agreement • March 31st, 1997 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSLicense Agreement • November 15th, 1999 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.259 AMENDMENT NO. 2 TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDMENT NO. 2 TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made on the 25th day of June, 2003, by and among Ligand...Registration Rights Agreement • August 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Sales AgreementLigand Pharmaceuticals Inc • March 26th, 2012 • Pharmaceutical preparations • New York
Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
EXHIBIT 2.1 PURCHASE AGREEMENTPurchase Agreement • September 11th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
ADOPTION AGREEMENT FOR SMITH BARNEY INC. EXECCHOICE(R) NONQUALIFIED DEFERRED COMPENSATION PLANTrust Agreement • May 7th, 2004 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 4.4 LIGAND PHARMACEUTICALS INCORPORATED THIS SECURITY AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY APPLICABLE STATE...Ligand Pharmaceuticals Inc • January 13th, 2003 • Pharmaceutical preparations
LOCK-UP AGREEMENTLock-Up Agreement • December 9th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.284 [Ligand Letterhead] March 11, 2005 Andres Negro-Vilar, M.D., Ph.D. Executive Vice President, Research and Development, & Chief Scientific Officer LIGAND PHARMACEUTICALS INCORPORATED 10275 Science Center Drive San Diego, CA 92121 Dear...Ligand Pharmaceuticals Inc • December 9th, 2005 • Pharmaceutical preparations
EXHIBIT 10.269 LIGAND PHARMACEUTICALS INCORPORATED STOCK OPTION AGREEMENT RECITALS A. The Board has adopted the Plan for the purpose of retaining the services of selected Employees, non-employee members of the Board (or the board of directors of any...Ligand Pharmaceuticals Inc • March 12th, 2004 • Pharmaceutical preparations • California
1 EXHIBIT 10.11 AMENDMENT NO. 1 TO SERVICE AGREEMENT This Amendment No. 1 to Service Agreement (the "Amendment") is made between Seragen, Inc., a Delaware corporation having a usual place of business at 97 South Street, Hopkinton, Massachusetts...Service Agreement • July 9th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.3 OPTION AND ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 9th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.168 COLLABORATION AGREEMENTCollaboration Agreement • March 31st, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
EXHIBIT 10.289 LIGAND PHARMACEUTICALS INCORPORATED STOCK ISSUANCE AGREEMENT This STOCK ISSUANCE AGREEMENT is made this _____ day of ______________, 200__ (the "Grant Date"), by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation,...Stock Issuance Agreement • January 13th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.287 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND...Development and License Agreement • January 13th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) ----------------------------Joint Filing Agreement • September 23rd, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
